Viva Biotech Holdings (VBIZF)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 950.77 Million CNY | 4.85% |
| 2022 | 906.76 Million CNY | -62.47% |
| 2021 | 2.41 Billion CNY | -13.79% |
| 2020 | 2.8 Billion CNY | 11374.56% |
| 2019 | 24.42 Million CNY | 1209.6% |
| 2018 | 1.86 Million CNY | -21.04% |
| 2017 | 2.36 Million CNY | -16.63% |
| 2016 | 2.83 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 861.2 Million CNY | 0.0% |
| 2024 Q1 | 861.2 Million CNY | -9.42% |
| 2023 FY | 950.77 Million CNY | 4.85% |
| 2023 Q1 | 619.11 Million CNY | -31.72% |
| 2023 Q4 | 950.77 Million CNY | 0.0% |
| 2023 Q3 | 950.77 Million CNY | 53.57% |
| 2023 Q2 | 619.11 Million CNY | 0.0% |
| 2022 Q4 | 906.76 Million CNY | 0.0% |
| 2022 FY | 906.76 Million CNY | -62.47% |
| 2022 Q3 | 906.76 Million CNY | -61.77% |
| 2022 Q2 | 2.37 Billion CNY | 0.0% |
| 2022 Q1 | 2.37 Billion CNY | -1.81% |
| 2021 Q1 | 2.16 Billion CNY | -22.68% |
| 2021 Q3 | 2.41 Billion CNY | 11.5% |
| 2021 Q4 | 2.41 Billion CNY | 0.0% |
| 2021 FY | 2.41 Billion CNY | -13.79% |
| 2021 Q2 | 2.16 Billion CNY | 0.0% |
| 2020 Q3 | 2.8 Billion CNY | 411.52% |
| 2020 FY | 2.8 Billion CNY | 11374.56% |
| 2020 Q1 | 547.88 Million CNY | 2143.23% |
| 2020 Q4 | 2.8 Billion CNY | 0.0% |
| 2020 Q2 | 547.88 Million CNY | 0.0% |
| 2019 Q3 | 24.42 Million CNY | -23.03% |
| 2019 Q1 | 31.73 Million CNY | 1601.45% |
| 2019 FY | 24.42 Million CNY | 1209.6% |
| 2019 Q4 | 24.42 Million CNY | 0.0% |
| 2019 Q2 | 31.73 Million CNY | 0.0% |
| 2018 FY | 1.86 Million CNY | -21.04% |
| 2018 Q3 | 222.46 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q4 | 1.86 Million CNY | -99.16% |
| 2017 FY | 2.36 Million CNY | -16.63% |
| 2016 FY | 2.83 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 8000.00 USD | -11884600.0% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -357825.725% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -54060.488% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -4580.859% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -635385.984% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -1188370.0% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -555162.512% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 91.54% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -11405.034% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -4447.209% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -1621222.602% |
| Mesoblast Limited | 100.29 Million USD | -847.98% |
| Marizyme, Inc. | 667.12 Thousand USD | -142417.564% |
| Genus plc | 228.2 Million USD | -316.642% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -472.395% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -17249101.742% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | 2.21 Million USD | -42921.538% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -67670.544% |
| IMV Inc. | 27.39 Million USD | -3370.166% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -17421.045% |
| MultiCell Technologies, Inc. | 36.43 USD | -2609870885.452% |
| ONE Bio Corp. | 592.19 Thousand USD | -160450.356% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -1609.66% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -42612.309% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -77302.002% |
| Biomind Labs Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -171337.639% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -3758056.449% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -49981.223% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -295172.05% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 150 Thousand USD | -633750.667% |
| Enzolytics Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -578917.691% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -6092.367% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -21336883.842% |
| Genscript Biotech Corporation | 287.12 Million USD | -231.132% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -752679.845% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -414559.101% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -413836.985% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 1064.00 USD | -89358546.617% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -635385.984% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -674209.22% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -12058.323% |
| SYBLEU INC | 300 Thousand USD | -316825.333% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -257528.662% |
| International Stem Cell Corporation | 445 Thousand USD | -213557.528% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -11565.963% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -207947.265% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -81792.851% |
| PureTech Health plc | 18.25 Million USD | -5109.732% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -633750.667% |
| IXICO plc | 275 Thousand USD | -345636.727% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -7930.881% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -3513.881% |
| CSL Limited | 11.23 Billion USD | 91.54% |
| Cellectis S.A. | 36.21 Million USD | -2525.645% |